Citation Impact
Citing Papers
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
A Genomewide Search for Ribozymes Reveals an HDV-Like Sequence in the Human CPEB3 Gene
2006 StandoutScienceNobel
Immunogenicity of the Epitope of the Foot-and-Mouth Disease Virus Fused With a Hepatitis B Core Protein as Expressed in Transgenic Tobacco
2005
Segments of Puumala Hantavirus Nucleocapsid Protein Inserted into Chimeric Polyomavirus-Derived Virus-Like Particles Induce a Strong Immune Response in Mice
2004
Hierarchical design of pseudosymmetric protein nanocages
2024 StandoutNatureNobel
A protein particle vaccine containing multiple malaria epitopes
1997
A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects
1997
Protection fromPlasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use
1998
HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA
1991 StandoutNobel
Immunogenicity of Ty-VLP bearing a CD8+ T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus
2000
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation
1989
Advances in vaccine adjuvants
1999
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine
1990
Immunization with Tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection
1992
The basis for HIV immunotherapeutic vaccines
2001
Genetic Diversity and Evolution of Retroviruses
1992
Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles
1992
Atomic structure of the ectodomain from HIV-1 gp41
1997 StandoutNature
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1998 StandoutNature
Virus-like particles in vaccine development
2010
Functional Classification and Experimental Dissection of Long Noncoding RNAs
2018 Standout
Ribosome gymnastics—Degree of difficulty 9.5, style 10.0
1990
Synthesis of mumps virus nucleocapsid protein in yeast Pichia pastoris
2003
Structural and functional aspects of RNA pseudoknots
1992
Increased Incorporation of Chimeric Human Immunodeficiency Virus Type 1 gp120 Proteins into Pr55gagVirus-like Particles by an Epstein–Barr Virus gp220/350-Derived Transmembrane Domain
1997
A statistically defined endpoint titer determination method for immunoassays
1998
Virus-like particles as HIV-1 vaccines
2004
The role of γ δ T cells in generating antiviral factors and β-chemokines in protection against mucosal simian immunodeficiency virus infection
2000
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Polyvalent recombinant antigens: a new vaccine strategy
1988
Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2
2008
SHAPE-directed RNA secondary structure prediction
2010
Secondary Structure of Vertebrate Telomerase RNA
2000 StandoutNobel
HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line
2011
A rational basis for mucosal vaccination against HIV infection
1999
The where, what and how of ribosomal frameshifting in retroviral protein synthesis
1990
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Mechanisms of Exogenous Antigen Presentation by MHC Class I Molecules in Vitro and in Vivo: Implications for Generating CD8+ T Cell Responses to Infectious Agents, Tumors, Transplants, and Vaccines
1999
Self-assembling protein nanoparticles in the design of vaccines
2015
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
2011 StandoutNature
Production and Characterization of Simian-Human Immunodeficiency Virus-Like Particles
2000
Adenosyl Radical: Reagent and Catalyst in Enzyme Reactions
2010
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
2005 StandoutNature
Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles
1995
Treatment of multiple sclerosis: recent trials and future perspectives
1999
Crystal structure of an HIV-binding recombinant fragment of human CD4
1990 StandoutNatureNobel
Teaching Surgical Skills — Changes in the Wind
2006 Standout
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
1998 StandoutNature
Enzymatic functionalization of carbon–hydrogen bonds
2010 StandoutNobel
HIV as the cause of AIDS
1996 StandoutNobel
[34] Use of fusions to viral coat proteins as antigenic carriers for vaccine development
2000
A transient three-plasmid expression system for the production of high titer retroviral vectors
1995
Versatile vectors to study recoding: conservation of rules between yeast and mammalian cells
1995
Induction of T cell response by bluetongue virus core-like particles expressing a T cell epitope of the M1 protein of influenza A virus
1998
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
Autocatalytic RNA cleavage in the human β-globin pre-mRNA promotes transcription termination
2004 Nature
Multiple Sclerosis
2000 Standout
Intergenic transcription and transinduction of the human β-globin locus
1997
Formation of Immunogenic Virus-like Particles by Inserting Epitopes into Surface-Exposed Regions of Hamster Polyomavirus Major Capsid Protein
2000
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Three-Dimensional Analysis of a Viral RNA Replication Complex Reveals a Virus-Induced Mini-Organelle
2007
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Selective Autophagy Regulates Insertional Mutagenesis by the Ty1 Retrotransposon in Saccharomyces cerevisiae
2011 StandoutNobel
Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant
1992
Functions of the auxiliary gene products of the human immunodeficiency virus type 1
1990
A new foreign policy: MHC class I molecules monitor the outside world
1996
Fully mobilizing host defense: Building better vaccines
1998
Interaction of Human Immunodeficiency Virus Type 1 Tat-Derived Peptides with TAR RNA
1995
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death
1995 StandoutNobel
Human 5′ → 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites
2004 Nature
Virus-like particles: Designing an effective AIDS vaccine
2006
Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8+ cytotoxic T lymphocytes
1996
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus
2001
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
A chimaeric plant virus vaccine protects mice against a bacterial infection
1999
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation.
1991
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Modeling and automation of sequencing-based characterization of RNA structure
2011 StandoutNobel
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Multiplexed RNA structure characterization with selective 2′-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq)
2011 StandoutNobel
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
1990
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
1990 Science
Finding errors in DNA sequences.
1992 StandoutNobel
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
ATP-independent diffusion of double-stranded RNA binding proteins
2012 StandoutNobel
Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
1991
The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis.
1994 StandoutNobel
INTERACTION OF ANTIGENS AND ANTIBODIES AT MUCOSAL SURFACES
1997
Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences
2006
tRNAscan-SE: A Program for Improved Detection of Transfer RNA Genes in Genomic Sequence
1997 Standout
Incorporation of chimeric gag protein into retroviral particles
1990
A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
1990
Pathogenesis of human immunodeficiency virus infection
1993
Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.
1996 StandoutNobel
A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines
1994
Multiple Molecular Determinants for Retrotransposition in a Primer tRNA
1995
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Virus-like particles: flexible platforms for vaccine development
2007
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
1999
Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates
1992
Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells
1995
Immunological Memory and Protective Immunity: Understanding Their Relation
1996 StandoutScience
A 1.3-Å resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation
1998 StandoutNobel
Conserved Structures and Diversity of Functions of RNA-Binding Proteins
1994 StandoutScience
OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation
2014 StandoutNobel
Secondary Structure is the Major Determinant for Interaction of HIV rev Protein with RNA
1990 Science
Characterization of a Human TAR RNA-Binding Protein That Activates the HIV-1 LTR
1991 Science
Fragments of the HIV-1 Tat Protein Specifically Biand TAR RNA
1990 StandoutScienceNobel
ATP-sensitive potassium channel (K ATP )–dependent regulation of cardiotropic viral infections
2011 StandoutNobel
Works of Sally E. Adams being referenced
HIV-1 TAT “activates” presynthesized RNA in the nucleus
1989
Therapeutic vaccination (p24‐VLP) of patients with advanced HIV‐1 infection in the pre‐HAART era does not alter CD4 cell decline
2001
Induction of single and dual cytotoxic T‐lymphocyte responses to viral proteins in mice using recombinant hybrid Ty–virus‐like particles
1996
Generation of diversity in the hierarchy of T-cell epitope responses following different routes of immunization with simian immunodeficiency virus protein
1995
The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice
1996
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview
1997
Synthesis of a gene for the HIV transactivator protein TAT by a novel single stranded approach involvingin vivogap repair
1988
A Human Factors Analysis of Technical and Team Skills Among Surgical Trainees During Procedural Simulations in a Simulated Operating Theatre
2005
Hybrid Ty Virus-Like Particles
1994
HIV expression strategies: Ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems
1988
A novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs)
1989
The functions and relationships of Ty-VLP proteins in yeast reflect those of mammalian retroviral proteins
1987
Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen
1994
Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles.
1993
Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion
1993
HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
1990
The expression of hybrid HIV:Ty virus-like particles in yeast
1987 Nature
Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant
1991
Complete nucleotide sequence of a mouse VL30 retro-element.
1988
Immunization of human HIV-seronegative volunteers with recombinant p17/p24
1993
Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.
1994
Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles.
1992
Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.
1992
Induction of Mucosal and Systemic Immunity to a Recombinant Simian Immunodeficiency Viral Protein
1992 Science
Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
1993